Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kern

Showing results (421-430 of 555) with videos related to

Pageof 56
Sort By:
The British Journal of Dermatology|January 23, 2023
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE studyJohannes S Kern, Eli Sprecher, Maria Florencia Fernandez, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2020
Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse modelDa Sun, Wenyu Sun, Song-Qi Gao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 2, 2009
Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrityJohannes S Kern, Stefan Loeckermann, Anja Fritsch, et al.
Investigative Ophthalmology & Visual Science|December 6, 2014
Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signalingJose-Andres C Portillo, Isaac Schwartz, Simona Zarini, et al.
The Journal of Pathology|October 11, 2011
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisitaZlatko Kopecki, Ruth M Arkell, Xanthe L Strudwick, et al.
The British Journal of Dermatology|January 17, 2025
Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE studyDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
Schizophrenia Bulletin|July 4, 2020
The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life SpanWaqas Ullah Khan, Zaid Ghazala, Heather Jane Brooks, et al.
Investigative Ophthalmology & Visual Science|July 20, 2018
D-cis-Diltiazem Can Produce Oxidative Stress in Healthy Depolarized Rods In VivoBruce A Berkowitz, Robert H Podolsky, Benjamin Farrell, et al.
The Journal of Pathology|October 24, 2007
Chronic colitis due to an epithelial barrier defect: the role of kindlin-1 isoformsJ S Kern, C Herz, E Haan, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 11, 2011
The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessmentsJohn A Troutman, Leslie M Foertsch, Petra S Kern, et al.
Pageof 56

Showing results (421-430 of 555) with videos related to

Sort By:
Pageof 56
The British Journal of Dermatology|January 23, 2023
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE studyJohannes S Kern, Eli Sprecher, Maria Florencia Fernandez, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2020
Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse modelDa Sun, Wenyu Sun, Song-Qi Gao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 2, 2009
Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrityJohannes S Kern, Stefan Loeckermann, Anja Fritsch, et al.
Investigative Ophthalmology & Visual Science|December 6, 2014
Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signalingJose-Andres C Portillo, Isaac Schwartz, Simona Zarini, et al.
The Journal of Pathology|October 11, 2011
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisitaZlatko Kopecki, Ruth M Arkell, Xanthe L Strudwick, et al.
The British Journal of Dermatology|January 17, 2025
Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE studyDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
Schizophrenia Bulletin|July 4, 2020
The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life SpanWaqas Ullah Khan, Zaid Ghazala, Heather Jane Brooks, et al.
Investigative Ophthalmology & Visual Science|July 20, 2018
D-cis-Diltiazem Can Produce Oxidative Stress in Healthy Depolarized Rods In VivoBruce A Berkowitz, Robert H Podolsky, Benjamin Farrell, et al.
The Journal of Pathology|October 24, 2007
Chronic colitis due to an epithelial barrier defect: the role of kindlin-1 isoformsJ S Kern, C Herz, E Haan, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 11, 2011
The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessmentsJohn A Troutman, Leslie M Foertsch, Petra S Kern, et al.
Pageof 56